Phase 3, randomized, double-blind, placebo controlled study of venetoclax combined with azacitidine versus azacitidine in treatment-naive patients with acute myeloid leukemia.

被引：5
|
作者：
Potluri, Jalaja
Xu, Tu
Hong, Wan-Jen
Mabry, Mack H.
机构：
[1] AbbVie Inc, Chicago, IL USA
[2] Genentech Inc, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.TPS7069
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS7069
引用
收藏
页数：5
相关论文
共 50 条
  • [31] A randomized, double-blind, placebo-controlled study of tamibarotene/azacitidine versus placebo/azacitidine in newly diagnosed adult patients selected for RARA plus HR-MDS (SELECT-MDS-1).
    Dezern, Amy Elizabeth
    Marconi, Giovanni
    Deeren, Dries
    Campelo, Maria Diez
    Lubbert, Michael
    Krishnamurthy, Pramila
    Nagy, Zsolt
    Basak, Grzegorz
    Morozova, Elena
    Geissler, Klaus
    Ofran, Yishai
    Kelley, Heather
    Volkert, Angela
    Baker, Kristen
    Kang-Fortner, Qing
    Madigan, Catherine
    Roth, David A.
    Kelly, Michael
    Fenaux, Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [32] Tumor lysis syndrome and infectious complications during treatment with venetoclax combined with azacitidine or decitabine in patients with acute myeloid leukemia
    Arora, Sankalp
    Zainaldin, Carl
    Bathini, Srilakshmi
    Gupta, Udita
    Worth, Sarah
    Bachiashvili, Kimo
    Bhatia, Ravi
    Godby, Kelly
    Jamy, Omer
    Rangaraju, Sravanti
    Diamond, Barry
    Oliver, Josh D.
    Salzman, Donna
    Di Stasi, Antonio
    Vachhani, Pankit
    LEUKEMIA RESEARCH, 2022, 117
  • [33] Single-institution experience of venetoclax combined with azacitidine in newly diagnosed acute myeloid leukemia patients
    Yu, Hong
    Wang, Chaomeng
    Lei, Yingying
    Li, Lijuan
    Wang, Huaquan
    Wang, Guojin
    Xing, Limin
    Guan, Jing
    Song, Jia
    Wu, Yuhong
    Liu, Hong
    Qu, Wen
    Wang, Xiaoming
    Shao, Zonghong
    Fu, Rong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 127
  • [34] Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
    Goadsby, Peter J.
    Wietecha, Linda A.
    Dennehy, Ellen B.
    Kuca, Bernice
    Case, Michael G.
    Aurora, Sheena K.
    Gaul, Charly
    BRAIN, 2019, 142 : 1894 - 1904
  • [35] Treatment Initiation of Venetoclax in Combination with Azacitidine or Decitabine in an Outpatient Setting in Patients with Untreated Acute Myeloid Leukemia
    Manda, Sudhir
    Anz, Bertrand
    Benton, Christopher
    Broun, E. Randolph
    Yimer, Habte
    Renshaw, John
    Geils, George F.
    Cruz, Jose
    Fanning, Suzanne
    Melear, Jason
    Sharman, Jeff P.
    Kang, Kingston
    Svensson, Anders
    Pai, Madhavi
    Donnellan, William
    BLOOD, 2021, 138
  • [36] Venetoclax Combined with Hypomethylating Agents for Treatment-Naive B/Myeloid Mixed Phenotype Acute Leukemia
    Wu, Di
    Chen, Wenlan
    Chen, Zhichao
    Li, Qiubai
    CASE REPORTS IN HEMATOLOGY, 2021, 2021
  • [37] Single-center experience of venetoclax combined with azacitidine in young patients with newly diagnosed acute myeloid leukemia
    Xu, Xuezhu
    Liu, Rui
    Chen, Hongli
    Yang, Ruoyu
    Gao, Gongzhizi
    He, Aili
    Wang, Fangxia
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2025, 16
  • [38] A prospective study of all-trans retinoic acid plus venetoclax and azacitidine in newly diagnosed acute myeloid leukemia.
    Gu, Chengyuan
    Wang, Ruju
    Kang, Huizhu
    He, Xuefeng
    Chen, Jun
    Lin, Zhihong
    Liu, Yuejun
    Yang, Ting
    Wu, Depei
    Han, Yue
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [39] Ibrutinib versus placebo in patients with asymptomatic, treatment-naive early stage chronic lymphocytic leukemia (CLL): primary endpoint results of the phase 3 double-blind, placebo-controlled randomized CLL12 trial
    Langerbeins, P.
    Bahlo, J.
    Rhein, C.
    Gerwin, H.
    Cramer, P.
    Fuerstenau, M.
    Al-Sawaf, O.
    von Tresckow, J.
    Fink, A. -M.
    Kreuzer, K. -A.
    Vehling-Kaiser, U.
    Tausch, E.
    Mueller, L.
    Eckart, M. J.
    Schlag, R.
    Freier, W.
    Gaska, T.
    Balser, C.
    Reiser, M.
    Stauch, M.
    Wendtner, C. -M.
    Fischer, K.
    Stilgenbauer, S.
    Eichhorst, B.
    Hallek, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 17 - 17
  • [40] A real-world study of infectious complications of venetoclax combined with decitabine or azacitidine in adult acute myeloid leukemia
    Zhu, Li-xia
    Chen, Rong-rong
    Wang, Lu-lu
    Sun, Jia-nai
    Zhou, De
    Li, Li
    Qian, Jie-jing
    Zhang, Yi
    Tong, Hong-yan
    Yu, Wen-juan
    Meng, Hai-tao
    Mai, Wen-yuan
    Xie, Wan-zhuo
    Jin, Jie
    Ye, Xiu-jin
    Zhu, Hong-hu
    SUPPORTIVE CARE IN CANCER, 2022, 30 (08) : 7031 - 7038
12345